Saudi Arabia Radiotherapy Market Report 2022 to 2030

Saudi Arabia Radiotherapy Market Analysis

$ 3999

By 2030, it is anticipated that the Saudi Arabia Radiotherapy Market will reach a value of $210 Mn from $117 Mn in 2022, growing at a CAGR of 7.5% during 2022-30. The Radiotherapy Therapeutics Market in Saudi Arabia is dominated by a few domestic players such as IMCO Engineering & Construction Company, Saudi Technology and Equipment, and Cura Healthcare. The radiotherapy market in Saudi Arabia is segmented into different types, technologies, procedures, applications, and end-users. The major risk factors associated with awareness of radiotherapy shortage of skilled staff, government initiatives, and reimbursement policy. The demand for Saudi Arabia Radiotherapy is increasing on account of the rise in cancer cases in the country.

ID: IN10SAPH043 CATEGORY: Pharmaceuticals GEOGRAPHY: Saudi Arabia AUTHOR: Dr. Vishwa Modhia

Buy Now

Saudi Arabia Radiotherapy Market Analysis Summary

By 2030, it is anticipated that the Saudi Arabia Radiotherapy Market will reach a value of $210 Mn from $117 Mn in 2022, growing at a CAGR of 7.5% during 2022-30.

The Gulf region's largest country is the Kingdom of Saudi Arabia. Saudi Arabia is a Middle Eastern country with a high revenue that borders the Persian Gulf and the Red Sea. The Ministry of Health established the Saudi Cancer Registry (SCR), a population-based registry, in 1992. (MOH). In 2014, the Saudi Health Council's Department of National Registries in the National Center for Health Information took over SCR. The overall number of newly diagnosed cancer cases reported to the Saudi Cancer Registry (SCR) in 2016 was 17,602, according to the most recent SCR cancer incidence data. In 2021, there will be 364 Mega-Voltage Machines (MVMs) in 210 RT centers servicing a total population of 427.8 Mn.

Cancer is on the rise in Arab countries, and by 2030, the region's cancer cases are predicted to have increased 1.8-fold. Saudi Arabia's government spent 6.2% of its GDP on healthcare in 2020.

Saudi Arabia Radiotherapy Market Analysis

Market Dynamics

Market Growth Drivers Analysis

Cancer prevention, diagnosis, and treatment have all been prioritised by the Saudi Ministry of Health. Multiple public sectors, including the Ministry of Health, the Ministry of Higher Education through university hospitals, and specialised hospitals serving various governmental sectors (e.g., the Military, the National Guard Ministry, Arabian American Oil Company (ARAMCO), and the Ministry of Interior), provide oncology care throughout the Kingdom. In partnership with the Saudi National Cancer Center, the SLCA developed a set of guidelines tailored to our patient group, encompassing patient characteristics, disease biology, and the practice environment of systemic therapy for cancer. These aspects could boost Saudi Arabia's, Radiotherapy Market.

Market restrains.

In general, Saudi Arabia's radiation oncology facilities are developing, with more radiotherapy centres and precision technology than ever before, however, there is a substantial regional disparity in equipment distribution. With an increasing cancer burden both globally and locally, as well as a young population with an increasing life expectancy, the barriers to providing optimal healthcare are substantial. Although 80% of the region's countries have national cancer policies, only 45% of the programmes are operational. There is also a lack of research output on this subject, particularly in preventative cancer control measures. These factors may deter new entrants into the Saudi Arabia Radiotherapy Market.

Competitive Landscape

Key Players

IMCO Engineering & Construction Company - IMCO is a Saudi Arabian company that provides engineering, procurement, and construction services for various industries, including healthcare. The company offers radiation therapy equipment such as linear accelerators and brachytherapy systems
Saudi Technology and Equipment Company (SATECH) - SATECH is a Saudi Arabian company that provides medical equipment, including radiation therapy equipment such as linear accelerators, CT simulators, and brachytherapy systems
King Fahd Medical City (KFMC) - KFMC is a government-owned medical facility in Riyadh that provides a range of medical services, including radiation therapy. The facility has multiple linear accelerators and CT simulators for radiation therapy treatment
Cura Healthcare - Cura Healthcare is a Saudi Arabian company that specializes in the distribution and service of medical equipment, including radiation therapy equipment such as linear accelerators and CT simulators

Healthcare Policies and Reimbursement Scenarios

In Saudi Arabia, the regulations and reimbursement of radiotherapy are overseen by the Saudi Food and Drug Authority (SFDA) and the Council of Cooperative Health Insurance (CCHI). The SFDA is responsible for regulating the use of radiation in Saudi Arabia, including the use of radiotherapy. The Ministry of Health (MOH) regulates the Saudi healthcare system, and oncology services are available in a variety of public and private facilities around the kingdom. The Saudi Arabian national health insurance program, known as the General Organization for Social Insurance (GOSI), provides coverage for radiotherapy for eligible patients.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Radiotherapy Segmentation

By Type (Revenue, USD Billion):

External Beam Radiation Therapy
Linear Accelerators
Compact Advanced Radiotherapy Systems
Cyberknife
Gamma Knife
?Tomotherapy
Proton Therapy
Cyclotron
?Synchrotron
Internal Beam Radiation Therapy
Brachytherapy
Seeds
Applicators and Afterloaders
Electronic Brachytherapy
Systemic Radiation Therapy
?Others

?By Technology (Revenue, USD Billion):

External Beam Radiotherapy
Intensity-Modulated Radiation Therapy (IMRT)
Image-Guided Radiation Therapy (IGRT)
Stereotactic Radiation Therapy (SRT)
3D Conformal Radiation Therapy (3D-CRT)
Particle Therapy
Internal Beam Radiotherapy
Brachytherapy
High-Dose Rate Brachytherapy
Low-Dose Rate Brachytherapy
Image-Guided Brachytherapy
Pulse-Dose Rate Brachytherapy
Systemic Radiation Therapy
Intravenous Radiotherapy
Oral Radiotherapy?

By Application (Revenue, USD Billion):

Breast Cancer
Cervical Cancer
Colon and rectum Cancers
Stomach Cancer
Lung Cancer
Prostate Cancer
Skin Cancer
Liver Cancer
Other types of cancer

By End User (Revenue, USD Billion):

Hospitals
Radiotherapy Centers & Ambulatory Surgery Centers
?Cancer Research Institutes

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.